KalVista Pharmaceuticals (NasdaqGM:KALV) Earnings call Transcript

KalVista Pharmaceuticals (NasdaqGM:KALV) Earnings call March 25, 2026 08:30 AM ET Company ParticipantsAmy Li - SVP Equity Research of Biotechnology and Large Cap PharmaBen Palleiko - CEO and DirectorBrian Piekos - CFOJulian Pino - Senior Associate of Biotechnology Equity ResearchNicole Sweeny - Chief Commercial OfficerPaul Audhya - Chief Medical OfficerRyan Baker - Head of Investor RelationsStacy Ku - Biotechnology Equity ResearchTazeen Ahmad - Managing Director in US Equity ResearchConference Call Particip ...